These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 7490801
1. Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma. Holmäng S, Borghede G. J Urol; 1996 Jan; 155(1):100-2. PubMed ID: 7490801 [Abstract] [Full Text] [Related]
2. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Cowan RA, McBain CA, Ryder WD, Wylie JP, Logue JP, Turner SL, Van der Voet J, Collins CD, Khoo VS, Read GR. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):197-207. PubMed ID: 15093917 [Abstract] [Full Text] [Related]
3. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study. Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H. Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582 [Abstract] [Full Text] [Related]
4. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Choquenet C, Reboul F. J Urol; 1996 Oct 01; 156(4):1258-62. PubMed ID: 8808849 [Abstract] [Full Text] [Related]
5. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Chung PW, Bristow RG, Milosevic MF, Yi QL, Jewett MA, Warde PR, Catton CN, McLean M, Moore M, Tannock IF, Gospodarowicz MK. Urol Oncol; 2007 Oct 01; 25(4):303-9. PubMed ID: 17628296 [Abstract] [Full Text] [Related]
6. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Fokdal L, Høyer M, von der Maase H. Acta Oncol; 2004 Oct 01; 43(8):749-57. PubMed ID: 15764221 [Abstract] [Full Text] [Related]
7. Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose. Whillis D, Howard GC, Kerr GR, Fowler J, Hargreave TB, Chisholm GD. J R Coll Surg Edinb; 1992 Feb 01; 37(1):42-5. PubMed ID: 1573607 [Abstract] [Full Text] [Related]
8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. Urology; 2004 Sep 01; 64(3):488-93. PubMed ID: 15351577 [Abstract] [Full Text] [Related]
9. Management of muscle-invasive bladder cancer in Victoria, 1990-1995. Millar JL, Frydenberg M, Toner G, Syme R, Thursfield V, Giles GG, Urology Study Committee of the Victorian Co-operative Oncology Group. ANZ J Surg; 2006 Mar 01; 76(3):113-9. PubMed ID: 16626343 [Abstract] [Full Text] [Related]
10. Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. Hoskin PJ, Rojas AM, Phillips H, Saunders MI. Cancer; 2005 Jun 01; 103(11):2287-97. PubMed ID: 15834926 [Abstract] [Full Text] [Related]
11. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Piet AH, Hulshof MC, Pieters BR, Pos FJ, de Reijke TM, Koning CC. Strahlenther Onkol; 2008 Jun 01; 184(6):313-8. PubMed ID: 18535807 [Abstract] [Full Text] [Related]
12. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study. Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB. J Urol; 2001 Jan 01; 165(1):56-60; discussion 60-1. PubMed ID: 11125363 [Abstract] [Full Text] [Related]
13. [Comparative study of pure epidermoid carcinoma of the bladder and transitional cell carcinoma with squamous or mixed differentiated foci]. Budía Alba A, Queipo Zaragozá JA, Pérez Ebrí ML, Fuster Escrivá A, Vera Donoso DC, Vera Sempere FJ, Jiménez Cruz JF. Actas Urol Esp; 1999 Feb 01; 23(2):111-8. PubMed ID: 10327674 [Abstract] [Full Text] [Related]
14. Carcinoma in a bladder diverticulum: presentation and treatment outcome. Golijanin D, Yossepowitch O, Beck SD, Sogani P, Dalbagni G. J Urol; 2003 Nov 01; 170(5):1761-4. PubMed ID: 14532771 [Abstract] [Full Text] [Related]
15. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma. Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S. Scand J Urol Nephrol; 2002 Nov 01; 36(5):339-43. PubMed ID: 12487737 [Abstract] [Full Text] [Related]
16. APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Sak SC, Harnden P, Johnston CF, Paul AB, Kiltie AE. Clin Cancer Res; 2005 Sep 01; 11(17):6205-11. PubMed ID: 16144922 [Abstract] [Full Text] [Related]
17. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer. Koukourakis MI, Tsolos C, Touloupidis S. Urology; 2007 Feb 01; 69(2):245-50. PubMed ID: 17320657 [Abstract] [Full Text] [Related]
18. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study]. Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A. Arch Esp Urol; 1997 Jun 01; 50(5):448-54; discussion 454-6. PubMed ID: 9382586 [Abstract] [Full Text] [Related]
19. Long-term followup of a bladder carcinoma cohort: questionable value of radical radiotherapy. Holmäng S, Hedelin H, Borghede G, Johansson SL. J Urol; 1997 May 01; 157(5):1642-6. PubMed ID: 9112495 [Abstract] [Full Text] [Related]
20. [Cancer of the bladder. Results of radiotherapy after partial cystectomy]. Di Pietrantonj F, Capirci C, Proietti A, Cardinali M. Radiol Med; 1985 May 01; 71(7-8):510-6. PubMed ID: 4081133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]